These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 15003156

  • 21. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
    Tu YT, Tao J, Liu YQ, Li Y, Huang CZ, Zhang XB, Lin Y.
    Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
    [Abstract] [Full Text] [Related]

  • 22. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K.
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [Abstract] [Full Text] [Related]

  • 23. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
    Fukunaga S, Maeda K, Noda E, Inoue T, Wada K, Hirakawa K.
    Oncology; 2006 Oct; 71(3-4):204-11. PubMed ID: 17641542
    [Abstract] [Full Text] [Related]

  • 24. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].
    Wang XB, Yang QX, Pei XJ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622
    [Abstract] [Full Text] [Related]

  • 25. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
    Loges S, Clausen H, Reichelt U, Bubenheim M, Erbersdobler A, Schurr P, Yekebas E, Schuch G, Izbicki J, Pantel K, Bokemeyer C, Fiedler W.
    Clin Cancer Res; 2007 Jan 01; 13(1):76-80. PubMed ID: 17200341
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A.
    Br J Cancer; 2006 Jul 03; 95(1):75-9. PubMed ID: 16755294
    [Abstract] [Full Text] [Related]

  • 29. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
    Strohmeyer D, Strauss F, Rössing C, Roberts C, Kaufmann O, Bartsch G, Effert P.
    Anticancer Res; 2004 Jul 03; 24(3a):1797-804. PubMed ID: 15274358
    [Abstract] [Full Text] [Related]

  • 30. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA.
    Cancer Res; 2009 Jun 01; 69(11):4708-15. PubMed ID: 19487287
    [Abstract] [Full Text] [Related]

  • 31. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
    Hu SE, Zhang YJ, Cui YM, Zhang HQ.
    Ai Zheng; 2005 Sep 01; 24(9):1076-9. PubMed ID: 16159428
    [Abstract] [Full Text] [Related]

  • 32. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X, Yang D, Hu J, Hao X, Gao J, Mao Z.
    Anticancer Res; 2008 Sep 01; 28(3A):1659-66. PubMed ID: 18630523
    [Abstract] [Full Text] [Related]

  • 33. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
    Lam JS, Yamashiro J, Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW, Reiter RE.
    Clin Cancer Res; 2005 Apr 01; 11(7):2591-6. PubMed ID: 15814638
    [Abstract] [Full Text] [Related]

  • 34. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH.
    Eur Surg Res; 2007 Apr 01; 39(4):229-38. PubMed ID: 17446709
    [Abstract] [Full Text] [Related]

  • 35. Lymphatic vessel density and lymph node metastasis in prostate cancer.
    Zeng Y, Opeskin K, Horvath LG, Sutherland RL, Williams ED.
    Prostate; 2005 Nov 01; 65(3):222-30. PubMed ID: 15948136
    [Abstract] [Full Text] [Related]

  • 36. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors.
    Qi L, Robinson WA, Brady BM, Glode LM.
    Anticancer Res; 2003 Nov 01; 23(5A):3917-22. PubMed ID: 14666697
    [Abstract] [Full Text] [Related]

  • 37. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
    Tesan T, Gustavsson H, Welén K, Damber JE.
    BJU Int; 2008 Sep 01; 102(8):1034-9. PubMed ID: 18489523
    [Abstract] [Full Text] [Related]

  • 38. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
    Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.
    J Pathol; 2007 Sep 01; 213(1):56-64. PubMed ID: 17674348
    [Abstract] [Full Text] [Related]

  • 39. Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study.
    Yao JL, Ryan CK, Francis CW, Kohli M, Taubman MB, Khorana AA.
    Cancer Invest; 2009 May 01; 27(4):430-4. PubMed ID: 19219655
    [Abstract] [Full Text] [Related]

  • 40. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N, Yano H, Komai K, Nishida T, Kamura T, Kojiro M.
    Cancer; 2004 Sep 15; 101(6):1364-74. PubMed ID: 15368324
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.